PAA 2.56% 20.0¢ pharmaust limited

Ann: FDA Outlines Pathway to Accelerated Approval for MPL in MND, page-59

  1. 2,708 Posts.
    lightbulb Created with Sketch. 2824
    cash for trial is something to consider. If we look at cash in the bank, R&D, Oppy conversion and grants would it be scrapping enough together? If not, when would a raise occur?

    It would make more sense to raise once the trial design and sites are known. I think this won’t be until after application to Healy platform trial is firm as costs could otherwise be double.

    Does anyone if and when the Healy trial application process has commenced? I am assuming any formal application is pending the top line results but hopefully the wheels are in motion.

    often it will be a two-for-one announcement Insto raise + Healy trial announced with retail SPP off the back.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.005(2.56%)
Mkt cap ! $97.22M
Open High Low Value Volume
19.5¢ 20.0¢ 19.5¢ $106.8K 538.5K

Buyers (Bids)

No. Vol. Price($)
1 98143 20.0¢
 

Sellers (Offers)

Price($) Vol. No.
20.5¢ 140116 6
View Market Depth
Last trade - 13.23pm 30/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.